Trial Profile
Exploration of VEGF-expression and 89Zirconium-bevacizumab uptake in paediatric high grade glioma and diffuse intrinsic pontine glioma imaged by PET.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diffuse intrinsic pontine glioma; Glioma
- Focus Diagnostic use
- 05 Jul 2017 New trial record